In accordance with Regulation 30 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Orchid Pharma has informed that it enclosed the Proceedings of the 29th Annual General Meeting (AGM) of the Company held on July 15, 2022.
The above information is a part of company’s filings submitted to BSE.